R.H. Dinel Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.64M | Hold |
67,935
| – | – | 1.26% | 22 |
|
|
2026
Q1 | $1.91M | Hold |
67,935
| – | – | 1.54% | 20 |
|
|
2025
Q4 | $1.69M | Hold |
67,935
| – | – | 1.24% | 21 |
|
|
2025
Q3 | $1.73M | Hold |
67,935
| – | – | 1.12% | 22 |
|
|
2025
Q2 | $1.65M | Sell |
67,935
-2,975
| -4% | -$69.4K | 1.1% | 23 |
|
|
2025
Q1 | $1.8M | Hold |
70,910
| – | – | 1.23% | 23 |
|
|
2024
Q4 | $1.88M | Hold |
70,910
| – | – | 1.26% | 23 |
|
|
2024
Q3 | $2.05M | Hold |
70,910
| – | – | 1.28% | 23 |
|
|
2024
Q2 | $1.98M | Hold |
70,910
| – | – | 1.27% | 23 |
|
|
2024
Q1 | $1.97M | Hold |
70,910
| – | – | 1.26% | 22 |
|
|
2023
Q4 | $2.04M | Sell |
70,910
-2,125
| -3% | -$64.2K | 1.39% | 22 |
|
|
2023
Q3 | $2.42M | Hold |
73,035
| – | – | 1.75% | 18 |
|
|
2023
Q2 | $2.68M | Hold |
73,035
| – | – | 1.88% | 16 |
|
|
2023
Q1 | $2.98M | Hold |
73,035
| – | – | 2.24% | 16 |
|
|
2022
Q4 | $3.74M | Hold |
73,035
| – | – | 3.35% | 12 |
|
|
2022
Q3 | $3.2M | Hold |
73,035
| – | – | 3.18% | 11 |
|
|
2022
Q2 | $3.83M | Hold |
73,035
| – | – | 3.45% | 9 |
|
|
2022
Q1 | $3.78M | Hold |
73,035
| – | – | 2.91% | 11 |
|
|
2021
Q4 | $4.31M | Hold |
73,035
| – | – | 2.97% | 11 |
|
|
2021
Q3 | $3.14M | Hold |
73,035
| – | – | 2.36% | 12 |
|
|
2021
Q2 | $2.86M | Hold |
73,035
| – | – | 2.04% | 15 |
|
|
2021
Q1 | $2.65M | Hold |
73,035
| – | – | 2.02% | 18 |
|
|
2020
Q4 | $2.69M | Buy |
73,035
+57,583
| +373% | +$2.11M | 2.16% | 16 |
|
|
2020
Q3 | $564K | Sell |
15,452
-1,581
| -9% | -$55.4K | 0.54% | 31 |
|
|
2020
Q2 | $528K | Hold |
17,033
| – | – | 0.51% | 33 |
|
|
2020
Q1 | $527K | Hold |
17,033
| – | – | 0.62% | 31 |
|
|
2019
Q4 | $633K | Hold |
17,033
| – | – | 0.56% | 36 |
|
|
2019
Q3 | $581K | Hold |
17,033
| – | – | 0.54% | 37 |
|
|
2019
Q2 | $700K | Hold |
17,033
| – | – | 0.65% | 32 |
|
|
2019
Q1 | $686K | Hold |
17,033
| – | – | 0.68% | 32 |
|
|
2018
Q4 | $705K | Buy |
+17,033
| New | +$707K | 0.79% | 29 |
|
|
2016
Q3 | $576K | Sell |
17,929
-1,791
| -9% | -$59.9K | 0.65% | 39 |
|
|
2016
Q2 | $659K | Hold |
19,720
| – | – | 0.77% | 34 |
|
|
2016
Q1 | $555K | Hold |
19,720
| – | – | 0.65% | 37 |
|
|
2015
Q4 | $604K | Hold |
19,720
| – | – | 0.68% | 35 |
|
|
2015
Q3 | $588K | Hold |
19,720
| – | – | 0.61% | 42 |
|
|
2015
Q2 | $627K | Hold |
19,720
| – | – | 0.59% | 47 |
|
|
2015
Q1 | $651K | Sell |
19,720
-4,243
| -18% | -$135K | 0.61% | 45 |
|
|
2014
Q4 | $708K | Sell |
23,963
-2,413
| -9% | -$69.2K | 0.63% | 45 |
|
|
2014
Q3 | $740K | Hold |
26,376
| – | – | 0.67% | 47 |
|
|
2014
Q2 | $743K | Hold |
26,376
| – | – | 0.68% | 44 |
|
|
2014
Q1 | $804K | Buy |
26,376
+2,898
| +12% | +$86.4K | 0.71% | 45 |
|
|
2013
Q4 | $682K | Buy |
+23,478
| New | +$683K | 0.6% | 46 |
|
Other funds holding PFE
R.H. Dinel Investment Counsel's PFE Position: Q2 2026 in Review
R.H. Dinel Investment Counsel held its Pfizer (PFE) position steady in Q2 2026 at 67,935 shares worth $1.64M. The position accounts for 1.26% of the portfolio, ranked #22.
R.H. Dinel Investment Counsel first reported a position in PFE in Q4 2013 and has held it in 43 quarters since. The position peaked at $4.31M in Q4 2021. 1,673 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- R.H. Dinel Investment Counsel held 67,935 shares of Pfizer worth $1.64M as of Q2 2026.
- R.H. Dinel Investment Counsel left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 1.26% of R.H. Dinel Investment Counsel's portfolio in Q2 2026, its #22 holding.
- R.H. Dinel Investment Counsel first reported a position in Pfizer in Q4 2013 and has held it in 43 quarters since.
- R.H. Dinel Investment Counsel's Pfizer position peaked at $4.31M in Q4 2021.
- 1,673 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on R.H. Dinel Investment Counsel's 13F filing for Q2 2026, filed 13 Jul 2026.